Table 2: Relationship between IDH, recurrent IDH, and presence of IDH risk factors.
|
|
Recurrent IDH |
IDH |
||||
Risk Factor |
N |
Yes |
No |
p-value |
Yes |
No |
P-Value |
(%) |
N (%) |
N (%) |
N (%) |
N (%) |
|||
Female gender |
24
(53.30%) |
8
(33.30%) |
16
(66.7%) |
0.74 |
13
(54.2%) |
11
(45.80%) |
0.7 |
Elderly
(Age ≥ 65 years) |
23
(51.10%) |
10
(43.5%) |
13
(56.5%) |
0.8 |
15
(65.2%) |
8
(34.8%) |
0.83 |
Diabetes mellitus |
27
(60%) |
10
(37%) |
17
(63%) |
0.8 |
16
(59.3%) |
11
(40.70%) |
0.64 |
Cardiovascular disease |
30
(66.30%) |
13
(43.30%) |
17
(56.7%) |
0.12 |
20
(66.7%) |
10
(33.3%) |
0.4 |
Anemia |
41
(91.10%) |
16
(39%) |
25
(61%) |
0.28 |
25
(61%) |
16
(39%) |
0.41 |
Hypoalbuminemia |
22
(48.90%) |
12
(54.50%) |
10
(45.5%) |
0.01 |
19
(86.4%) |
3
(13.60%) |
0.03 |
Using anti-HTN medicines* |
16
(35.60%) |
4
(25%) |
12
(75%) |
0.27 |
9
(56.25%) |
7
(43.80%) |
0.92 |
Pre-dialysis SBP < 100 mmHG |
37
(82. 2%) |
15
(40.50%) |
22
(59.5%) |
0.13 |
25
(67.60%) |
12
(32.40%) |
0.41 |
Uremic syndrome |
2
(4.40%) |
2
(100%) |
0
(0%) |
0.12 |
2
(100%) |
0
(0%) |
0.17 |
*Anti-HTN medications were discontinued 24 hours before the hemodialysis session.